Autologous Transplant in HIV Patients (BMT CTN 0803)
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This study is a Phase II, multicenter trial assessing overall survival after autologous
hematopoietic stem cell transplantation using a BEAM transplant regimen (carmustine,
etoposide, cytarabine, melphalan) in lymphoma patients with HIV.
Phase:
Phase 2
Details
Lead Sponsor:
Medical College of Wisconsin
Collaborators:
Blood and Marrow Transplant Clinical Trials Network National Cancer Institute (NCI) National Heart, Lung, and Blood Institute (NHLBI) National Marrow Donor Program